SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-016051
Filing Date
2019-08-08
Accepted
2019-08-08 16:26:26
Documents
48
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20190630_10q.htm 10-Q 575537
2 EXHIBIT 31.1 ex_153339.htm EX-31.1 10280
3 EXHIBIT 31.2 ex_153340.htm EX-31.2 10188
4 EXHIBIT 32.1 ex_153341.htm EX-32.1 4833
5 EXHIBIT 32.2 ex_153342.htm EX-32.2 5136
  Complete submission text file 0001437749-19-016051.txt   2751210

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dffn-20190630.xml EX-101.INS 462606
7 XBRL TAXONOMY EXTENSION SCHEMA dffn-20190630.xsd EX-101.SCH 33220
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20190630_cal.xml EX-101.CAL 26263
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20190630_def.xml EX-101.DEF 205241
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20190630_lab.xml EX-101.LAB 197939
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20190630_pre.xml EX-101.PRE 224865
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 191009960
SIC: 2834 Pharmaceutical Preparations